ArticleMaterials today. Bio2025
Antimicrobial hydrogel loaded with broccoli exosomes promotes anti-scarring healing of MRSA-infected wounds.
Article in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Hydrogels: current biomedical applications and future directions.Molecular biomedicine · 2026Review
- Recent progress of plant-derived extracellular vesicle-like nanoparticles integrated with biomaterials for skin repair.Journal of nanobiotechnology · 2026Review
- MRI-guided diagnosis and dual-pathway neuroprotection in ischemic strokeMaterials today. Bio · 2026Article
- Full-laser-enabled clean hierarchical structuring and multifunctional synergy for high-performance in vivo 3D-printed implants.Materials today. Bio · 2026Article
- Engineering Strategies for Plant-Derived Extracellular Vesicles: Modification, Drug Delivery Performance, and Synergistic Effects with Gel Composite Systems.Pharmaceutics · 2026Review
- Edible Plant-Derived Exosome-like Nanoparticles as Prebiotic Nanocarriers: Gut Microbiota Modulation and Functional Food Potential.Pharmaceutics · 2026Review
- Bionic design based on liposome-exosome hybrid nanoparticles for synergistic delivery of paeonol to achieve neuroprotection and improvement of motor function in Parkinson's disease model mice.Materials today. Bio · 2026Article
- Mechanistic Insights and Therapeutic Potential of Plant-Derived Exosome-Like Nanovesicles in Skin Tissue Regeneration.International journal of nanomedicine · 2026Review
- Biofluid-derived exosomes as next-generation biotherapeutic platforms to combat multidrug-resistant bacterial infections.Regenerative biomaterials · 2026Review
- Macrophage membrane coating enhances the therapeutic effects ofMaterials today. Bio · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The treatment of methicillin-resistant staphylococcus aureus (MRSA)-infected wounds is severely challenged by antibiotic resistance and persistent inflammation. In this study, a photocrosslinked composite hydrogel material (SK@E-Au@Exos) was designed using silk protein methacryloyl hydrogel (SK) as a carrier loaded with broccoli-derived exosomes (Bro-Exos) and epigallocatechin gallate-gold nanoparticles (E-Au NPs). The material promoted scarless wound repair through synergistic anti-infection combined with immune regeneration modulation. In vitro experiments showed that SK@E-Au@Exos has excellent biocompatibility and can rapidly kill MRSA and E.coli, remove Reactive Oxygen Species (ROS), inhibit inflammation, and promote cell proliferation, migration, and vascularization. Importantly, SK@E-Au@Exos can regulate the immune regenerative microenvironment by inhibiting the Nuclear Factor kappa B (NF-kB) pathway and driving the macrophage to an anti-inflammatory phenotype. In a mouse MRSA-infected wound model, SK@E-Au@Exos resisted infection, scavenged ROS, inhibited inflammation, and promoted collagen ordering and neovascularization, ultimately realizing scarless healing of the infected wound. This study demonstrated the ability of SK@E-Au@Exos to promote the temporal regulation of "antibacterial-anti-inflammatory-regenerative" in wounds and revealed the molecular mechanism of SK@E-Au@Exos in regulating the immune microenvironment through key signaling pathways. In summary, SK@E-Au@Exos effectively promotes anti-infection and anti-scar healing of wounds infected with multidrug-resistant bacteria through its photothermal sterilization effect and exosome-controlled release of anti-inflammatory and repair-promoting substances. This provides an innovative strategy for the clinical treatment of wounds infected with drug-resistant bacteria, combining antibacterial and regenerative functions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.